Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J August

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Journal for Immunotherapy of Cancer|January 21, 2021
Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infectionErin M Hall, Dwight E Yin, Rakesh K Goyal, et al.
Pediatric Blood & Cancer|March 11, 2021
Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemiaMaureen M O'Brien, Todd A Alonzo, Todd M Cooper, et al.
Cancer|October 20, 2020
Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology GroupDanielle M Zerr, Aaron M Milstone, Christopher C Dvorak, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 9, 2019
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T CellsAndrew M Stein, Stephan A Grupp, John E Levine, et al.
The Journal of Infectious Diseases|March 5, 2005
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancyDavid P Greenberg, Robert E Walker, Min-Shi Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2018
Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic LeukemiaKaren Thudium Mueller, Edward Waldron, Stephan A Grupp, et al.
Blood Advances|August 25, 2021
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphomaKaren Thudium Mueller, Stephan A Grupp, Shannon L Maude, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Successful classification of clinical pediatric leukemia genetic subtypes via structural variant detection using HiFi long-read sequencingLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
NPJ Genomic Medicine|April 9, 2026
Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohortLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Journal for Immunotherapy of Cancer|January 21, 2021
Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infectionErin M Hall, Dwight E Yin, Rakesh K Goyal, et al.
Pediatric Blood & Cancer|March 11, 2021
Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemiaMaureen M O'Brien, Todd A Alonzo, Todd M Cooper, et al.
Cancer|October 20, 2020
Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology GroupDanielle M Zerr, Aaron M Milstone, Christopher C Dvorak, et al.
The Journal of Infectious Diseases|August 18, 2001
Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infantsM S Lee, D P Greenberg, S H Yeh, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 9, 2019
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T CellsAndrew M Stein, Stephan A Grupp, John E Levine, et al.
The Journal of Infectious Diseases|March 5, 2005
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancyDavid P Greenberg, Robert E Walker, Min-Shi Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2018
Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic LeukemiaKaren Thudium Mueller, Edward Waldron, Stephan A Grupp, et al.
Blood Advances|August 25, 2021
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphomaKaren Thudium Mueller, Stephan A Grupp, Shannon L Maude, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Successful classification of clinical pediatric leukemia genetic subtypes via structural variant detection using HiFi long-read sequencingLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
NPJ Genomic Medicine|April 9, 2026
Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohortLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
Pageof 20